Showing results (101-110 of 113) with videos related to
Sort By:
Pageof 12
Antimicrobial Agents and Chemotherapy|December 3, 1998
Pharmacokinetics, distribution in serum lipoproteins and tissues, and renal toxicities of amphotericin B and amphotericin B lipid complex in a hypercholesterolemic rabbit model: single-dose studiesK M Wasan, A L Kennedy, S M Cassidy, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|February 1, 1996
Two novel molecular defects in the LCAT gene are associated with fish eye diseaseJ A Kuivenhoven, A F Stalenhoef, J S Hill, et al.Acta Medica Scandinavica|January 1, 1987
Hypoalphalipoproteinemia resembling fish eye diseaseJ Frohlich, G Hoag, R McLeod, et al.Journal of Pharmaceutical Sciences|November 7, 2000
Assessing plasma pharmacokinetics of cholesterol following oral coadministration with a novel vegetable stanol mixture to fasting ratsK M Wasan, L Holtorf, R Subramanian, et al.The Biochemical Journal|September 15, 1977
The effects of acute ethanol feeding and of chronic benfluorex administration on the activities of some enzymes of glycerolipid synthesis in rat liver and adipose tissueP H Pritchard, M Bowley, S L Burditt, et al.The Journal of Clinical Investigation|February 1, 1993
Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this diseaseH Funke, A von Eckardstein, P H Pritchard, et al.The Journal of Clinical Investigation|December 1, 1995
A unique genetic and biochemical presentation of fish-eye diseaseJ A Kuivenhoven, E J van Voorst tot Voorst, H Wiebusch, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 1, 1997
Heterogeneity at the CETP gene locus. Influence on plasma CETP concentrations and HDL cholesterol levelsJ A Kuivenhoven, P de Knijff, J M Boer, et al.Journal of Lipid Research|April 29, 1998
Characterization of recombinant human plasma lecithin: cholesterol acyltransferase (LCAT): N-linked carbohydrate structures and catalytic propertiesA G Lacko, A J Reason, C Nuckolls, et al.Atherosclerosis|May 1, 1994
Homozygous Tangier disease and cardiovascular diseaseC Serfaty-Lacrosniere, F Civeira, A Lanzberg, et al.Pageof 12